From the KEGG pathway for NSCLC (Supplementary Material Figure S2 and Figure 6C), we see several oncogenes, such as p53, p21, and Bax, were upregulated; Cyclin D1, Akt, MEK, ERK, and CDK4 were downregulated. The gene discussed is TP53; the disease is non-small cell lung carcinoma.